MolQTL: A comprehensive resource for molecular quantitative trait loci inhuman cancer.

MolQTL:人类癌症分子数量性状位点的综合资源。

基本信息

  • 批准号:
    10933833
  • 负责人:
  • 金额:
    $ 39.63万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-06-11 至 2026-03-31
  • 项目状态:
    未结题

项目摘要

Abstract important noncoding functional data Our group constructed a series of data portals for molQTLs, including data portals for expression QTLs (eQTLs), methylation QTLs (meQTLs), and splicing QTLs (sQTLs) based on a large number of cancer samples from TCGA. We demonstrated that these QTLs are associated with patient survival, and/or overlap with GWAS linkage disequilibrium regions. These related data resources have been broadly accessed since their releases, nucleotide polymorphisms (SNPs), the most common type of human genetic variants, play roles in shaping complex human traits and causing diseases. Most risk-related SNPs are located in regions and it remains a challenge to understand the effects and molecular mechanisms of SNPs . ) analysis is a statistical method to link genotyping and molecular phenotype data to interpret the effects of genetic variants in complex traits. Single , Molecular quantitative trait loci (MolQTL and highlighted discovery the opportunities t o understand the functional significance of genetic variants and to utilize the of molQTLs in precision medicine. The goal of this proposal is to enhance, expand, and promote our existing data resources that will bridge the genetic variants and different molecular features through molQTL analysis, providing a unique data resource for understanding the functional effects of genetic variants and facilitating access to and understanding of complex datasets for non-expert users. In Aim 1, we will enhance our existing data resources with additional analytical modules. We will identify molQTLs with highly efficient and accurate approaches (Aim 1.1). We will fine-map causal variants and causal effects through mediation analysis (Aim 1.2). We will evaluate anti-cancer drug response from molQTLs (Aim 1.3). We will determine the associations between genetic variants and immune features through molQTL analysis (Aim 1.4). In Aim 2, We will expand and promote our existing data resources. We will identifyRNA editing QTLs (edQTLs, Aim 2.1), 3'-UTR alternative polyadenylationQTLs (apaQTLs, Aim 2.2), andprotein QTLs (pQTLs, Aim 2.3). We will develop a unified data portal to integrate all the molQTL types described in this proposal (Aim 2.4). We will promote MolQTL and active interaction with the user community through providing written documents, video tutorial and hands-on workshops (Aim 2.5). We expect that our molQTL data portal will serve as a comprehensive, unique, and user- friendly data portal to identify and interpret the functional consequences of genetic variants.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Leng Han其他文献

Leng Han的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Leng Han', 18)}}的其他基金

Systematic Characterization of Small Nucleolar RNAs in Cancer
癌症中小核仁 RNA 的系统表征
  • 批准号:
    10914508
  • 财政年份:
    2023
  • 资助金额:
    $ 39.63万
  • 项目类别:
Characterization of Alternative Polyadenylation in Alzheimer's Disease
阿尔茨海默病中替代多腺苷酸化的表征
  • 批准号:
    10321676
  • 财政年份:
    2021
  • 资助金额:
    $ 39.63万
  • 项目类别:
MolQTL: A comprehensive resource for molecular quantitative trait loci in human cancer.
MolQTL:人类癌症分子数量性状位点的综合资源。
  • 批准号:
    10593169
  • 财政年份:
    2021
  • 资助金额:
    $ 39.63万
  • 项目类别:
MolQTL: A comprehensive resource for molecular quantitative trait loci in human cancer.
MolQTL:人类癌症分子数量性状位点的综合资源。
  • 批准号:
    10427368
  • 财政年份:
    2021
  • 资助金额:
    $ 39.63万
  • 项目类别:
Systematic Characterization of Small Nucleolar RNAs in Cancer
癌症中小核仁 RNA 的系统表征
  • 批准号:
    10277525
  • 财政年份:
    2021
  • 资助金额:
    $ 39.63万
  • 项目类别:
Characterization of Alternative Polyadenylation in Alzheimer's Disease
阿尔茨海默病中替代多腺苷酸化的表征
  • 批准号:
    10363157
  • 财政年份:
    2021
  • 资助金额:
    $ 39.63万
  • 项目类别:
MolQTL: A comprehensive resource for molecular quantitative trait loci in human cancer.
MolQTL:人类癌症分子数量性状位点的综合资源。
  • 批准号:
    10181442
  • 财政年份:
    2021
  • 资助金额:
    $ 39.63万
  • 项目类别:

相似海外基金

Administrative Core-001
行政核心-001
  • 批准号:
    10660381
  • 财政年份:
    2023
  • 资助金额:
    $ 39.63万
  • 项目类别:
GUMC Zebrafish Shared Resource Aquatic Habitat Modernization Project
GUMC斑马鱼共享资源水生栖息地现代化项目
  • 批准号:
    10734150
  • 财政年份:
    2023
  • 资助金额:
    $ 39.63万
  • 项目类别:
Capacity Development Core
能力发展核心
  • 批准号:
    10762289
  • 财政年份:
    2023
  • 资助金额:
    $ 39.63万
  • 项目类别:
Full Project 2
完整项目2
  • 批准号:
    10762291
  • 财政年份:
    2023
  • 资助金额:
    $ 39.63万
  • 项目类别:
Cancer Center Administration
癌症中心管理
  • 批准号:
    10842468
  • 财政年份:
    2023
  • 资助金额:
    $ 39.63万
  • 项目类别:
Whole Individual Comprehensive KnowlEDge: Somatic Mosaicism across Human Tissues (WICKed SMaHT)
整体综合知识:人体组织的体细胞镶嵌(WICKed SMaHT)
  • 批准号:
    10662869
  • 财政年份:
    2023
  • 资助金额:
    $ 39.63万
  • 项目类别:
Project ASTHMA - Aligning with Schools to Help Manage Asthma and Decrease Health Inequities
ASTHMA 项目 - 与学校合作,帮助管理哮喘并减少健康不平等
  • 批准号:
    10803747
  • 财政年份:
    2023
  • 资助金额:
    $ 39.63万
  • 项目类别:
ORION: Oncology Research Integration using OHDSI-based NLP (NCI Cancer Informatics Scholar)
ORION:使用基于 OHDSI 的 NLP 进行肿瘤学研究整合(NCI 癌症信息学学者)
  • 批准号:
    10891217
  • 财政年份:
    2023
  • 资助金额:
    $ 39.63万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10762142
  • 财政年份:
    2023
  • 资助金额:
    $ 39.63万
  • 项目类别:
A phase-1 trial of intraperitoneal 5-fluorouracil and oxaliplatin in patients with colorectal cancer and unresectable peritoneal metastasis.
腹腔注射 5-氟尿嘧啶和奥沙利铂治疗结直肠癌和不可切除的腹膜转移患者的 1 期试验。
  • 批准号:
    10722263
  • 财政年份:
    2023
  • 资助金额:
    $ 39.63万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了